A High-Throughput and Robust Relative Potency Assay Measuring Human Cytomegalovirus Infection in Epithelial Cells for Vaccine Development.

Saved in:
Bibliographic Details
Title: A High-Throughput and Robust Relative Potency Assay Measuring Human Cytomegalovirus Infection in Epithelial Cells for Vaccine Development.
Authors: Smiddy NM; Analytical Research and Development, Merck & Co., Inc., Rahway, NJ 07065, USA., Patel N; Analytical Research and Development, Merck & Co., Inc., Rahway, NJ 07065, USA., Troutman MC; Analytical Research and Development, Merck & Co., Inc., Rahway, NJ 07065, USA., Kearns KM; Analytical Research and Development, Merck & Co., Inc., Rahway, NJ 07065, USA., Davis ZP; Analytical Research and Development, Merck & Co., Inc., Rahway, NJ 07065, USA., Adams CS; Analytical Research and Development, Merck & Co., Inc., Rahway, NJ 07065, USA., Hofmann C; Analytical Research and Development, Merck & Co., Inc., Rahway, NJ 07065, USA., Warakomski DJ; Analytical Research and Development, Merck & Co., Inc., Rahway, NJ 07065, USA., Davis H; Vaccine Drug Product Development, Merck & Co., Inc., Rahway, NJ 07065, USA., Spatafore D; Process Research and Development, Merck & Co., Inc., Rahway, NJ 07065, USA., Kristopeit A; Process Research and Development, Merck & Co., Inc., Rahway, NJ 07065, USA., DePhillips P; Analytical Research and Development, Merck & Co., Inc., Rahway, NJ 07065, USA., Loughney JW; Analytical Research and Development, Merck & Co., Inc., Rahway, NJ 07065, USA.
Source: Vaccines [Vaccines (Basel)] 2025 Jun 10; Vol. 13 (6). Date of Electronic Publication: 2025 Jun 10.
Publication Type: Journal Article
Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2076-393X
DOI:10.3390/vaccines13060626